Cosentyx with methotrexate?

Can Cosentyx be used with methotrexate?

Yes. Cosentyx (secukinumab) is often combined with methotrexate for treating psoriatic arthritis. Studies show the combination improves joint symptoms more than Cosentyx alone.

What does clinical data show about the combination?

Clinical trials found that patients receiving both drugs had better ACR20 response rates than those using Cosentyx alone. The combination did not increase serious side effects beyond what was already expected from each drug individually.

How does this mix affect side effects?

Patients using Cosentyx and methotrexate together may see increased risk of infections and liver enzyme elevations. Doctors usually monitor blood work regularly for these issues.

Why do doctors prescribe both drugs?

Doctors add methotrexate to Cosentyx when patients show incomplete joint response to Cosentyx alone. Methotrexate helps control inflammation and may prolong the effect of Cosentyx.

How long does the combination stay effective?

Data indicate the combination remains effective over two years of treatment. Many patients maintain good symptom control without needing to switch to another drug.

What happens if you stop methotrexate while on Cosentyx?

Stopping methotrexate can lead to loss of joint control in some patients. Cosentyx by itself handles skin symptoms well, but joint symptoms may worsen without the ergänzende Wirkung of methotrexate.

When does Cosentyx patent expire?

Cosentyx patent expires in 2026 in the US. Biosimilars are expected to arrive after that date.